Govt expects GAVI
vaccine by February
The global alliance will supply 68 million doses that can cover 20 percent of the population
Govt expects GAVI
World agonises
over new curbs
Global coronavirus infections approach 60 million with the US reporting over 2,000 deaths in a day, first time since early May
What we know about
AstraZeneca vaccine
This month has seen a torrent of news about experimental vaccines to prevent COVID-19, with the latest development from AstraZeneca and the University of Oxford
Dosing error turns into
lucky punch for vaccine
AstraZeneca and Oxford University’s coronavirus vaccine can be around 90pc effective, when administered as a half dose followed by a full dose a month later
US plans to begin vaccination on Dec 11
US COVID-19 vaccine program head says plan is to be able to ship vaccines to the immunisation sites within 24 hours from the approval
Politics, science and the
race for a virus vaccine
The furious race to develop a vaccine played out against a presidential election, between a pharmaceutical giant and a biotech upstart, with the stakes as high as they co...
A new worry for COVID patients: air pollution
Experts say breathing unhealthy air damages the lungs and contracting COVID-19 under such conditions could raise the odds of dying from the disease
What does 95pc vaccine efficacy mean?
Efficacy and effectiveness are related to each other, but they’re not the same thing. And vaccine experts say it’s crucial not to mix them up
Pfizer seeks emergency vaccine approval
The move sets in motion an accelerated regulatory process that could allow the first Americans to get a vaccine by the middle of December
Reinfection unlikely for
at least 6 months: study
The findings offer some reassurance for the more than 51 million people worldwide who have been infected with the pandemic disease
